3rd Aug 2021
In addition to patents, pharmaceuticals and biopharmaceutical companies may achieve drug exclusivity in Europe through SPCs and regulatory data protection. This can exclude competitors and maximise return on substantial research and development investment.
2nd Jul 2021
Oral proceedings in case G1/21 took place today (2 July 2021) for the second time in case, after proceedings were adjourned at the first oral proceedings that took place last month. While we don’t know what the outcome of the oral proceedings will be, the proceedings were at least properly concluded and we can expect the written decision in due course.
14th May 2021
Since 2006, the European Patent Office has recognised “the creativity of inventors the world over, who use their technical, scientific and intellectual skills to contribute to technological progress, thereby driving and economic growth and improving people’s daily lives” at the annual European Inventor Awards. Sadly the 2020 European Inventor Awards were cancelled, just like Eurovision. As a result, the 15 inventors and inventor teams on the 2020 shortlist (along with us, loyal fans) have waited a whole year to find out who will emerge victorious.
3rd Mar 2021
Patents are, of necessity, filed at an early stage in the development of new technology, which means that patent filing trends can provide good insights today’s R&D and tomorrow’s leading technologies.Climate change targets are a major driver of innovation in today’s world. There is little doubt that innovative solutions are needed across the board if we are to achieve net-zero by 2050, and limit the rise in average global temperate to below 2C, as set out in the Paris Agreement.
10th Feb 2021
Last year, we reviewed a United Kingdom Intellectual Property Office (IPO) report on sectors of the economy which make the most intensive use of intellectual property (IP) rights, and how much these sectors contribute to the UK economy. This week, the European Patent Office and the European Union Intellectual Property Office have jointly published a report on the commercial benefit of owning IP rights to European companies
28th Jan 2021
Truly global patent specifications are the holy grail for applicants that file around the world. It’s easy to see why. If a specification meets the requirements of all the national patent offices in which protection is going to be sought the application will easier to prosecute and litigate locally and therefore cheaper overall.
1st Oct 2020
Last week, the European Patent Office (EPO), together with the International Energy Agency (IEA), released a detailed report on patenting activity in electricity storage between 2000 and 2018. An EPO press release is available on the EPO website along with the full report.
9th Sep 2020
The UK Intellectual Property Office published, on 7 September 2020, a call for views on the future of Artificial Intelligence and the UK IP framework.